Can We Limit Greed?
Greed is the common theme discussed with our two guests. First, Ralph talks to Maryland Congressman Jamie Raskin about CEO pay, progress on the minimum wage, and the possibility of impeaching Donald Trump. Then, advocate Jamie Love explains how greedy drug companies get away with gouging patients who need life-saving drugs.
Congressman Jamie Raskin is a returning Member of the House Judiciary Committee, the Committee on Oversight and Reform, and the Committee on House Administration. He is a new Member of the House Committee on Rules. For more than twenty-five years, Congressman Raskin has been a professor of constitutional law at American University’s Washington College of Law and has authored several books, including the bestseller “Overruling Democracy: The Supreme Court versus the American People” and the highly-acclaimed “We the Students: Supreme Court Cases For and About America’s Students.”
“Adam Smith, who was not only the author of “Wealth of Nations” but “The Theory of Moral Sentiments,” basically said the market has a place, but you’ve got to discipline it according to the other values of society. You’ve got to invest in education for young people and invest in older people. You’ve got to put it in a neighborhood of values that makes a real community. But Donald Trump is a reflection of a society where everything is for sale and market values trump everything else.”
Maryland Congressman Jamie Raskin
James Love is the Director of Knowledge Ecology International. The current focus of KEI is on the financing of research and development, intellectual property rights, prices for and access to new drugs, vaccines, and other medical technologies. Mr. Love also advises UN agencies, national governments, international and regional intergovernmental organizations, and public health NGOs.
“In most countries, you’re not allowed to raise the price of drugs beyond the rate of general inflation without some special justification. The U.S. is really an outlier in the ability to let companies do whatever they want in terms of raising prices. There are problems everywhere with drug prices, but the U.S. has the distinction of having the worst system in the world.”
Jamie Love, Director of Knowledge Ecology International